These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 28294047)
21. [Role of calcium and phosphate in atherosclerosis and vascular calcification]. Kurabayashi M Clin Calcium; 2013 Apr; 23(4):489-96. PubMed ID: 23545738 [TBL] [Abstract][Full Text] [Related]
22. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease. Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411 [TBL] [Abstract][Full Text] [Related]
23. Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease. Zhou C; Wang F; Wang JW; Zhang LX; Zhao MH Chin Med J (Engl); 2016 Oct; 129(19):2275-80. PubMed ID: 27647184 [TBL] [Abstract][Full Text] [Related]
24. [Role of parathyroid hormone in Klotho-FGF23 system]. Kimura T; Shiizaki K; Kuro-O M Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841 [TBL] [Abstract][Full Text] [Related]
25. Role of Klotho in bone and implication for CKD. Komaba H; Lanske B Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):298-304. PubMed ID: 29697410 [TBL] [Abstract][Full Text] [Related]
26. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study. Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324 [TBL] [Abstract][Full Text] [Related]
27. The predictive value of Klotho polymorphism, in addition to classical markers of CKD-MBD, for left ventricular hypertrophy in haemodialysis patients. Apostolović B; Cvetković T; Stefanović N; Apostolović S; Apostolović MA; Mitić B; Radovanović RV; Paunović K; Ignjatović A; Cvetković M; Stević N; Pavlović D Int Urol Nephrol; 2019 Aug; 51(8):1425-1433. PubMed ID: 31187426 [TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients. Sarmento-Dias M; Santos-Araújo C; Poínhos R; Oliveira B; Silva IS; Silva LS; Sousa MJ; Correia F; Pestana M Clin Nephrol; 2016 Mar; 85(3):135-41. PubMed ID: 26833300 [TBL] [Abstract][Full Text] [Related]
29. Calcium as a cardiovascular toxin in CKD-MBD. Moe SM Bone; 2017 Jul; 100():94-99. PubMed ID: 27576942 [TBL] [Abstract][Full Text] [Related]
30. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients]. Gan L; Zhou Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Hruska KA; Choi ET; Memon I; Davis TK; Mathew S Pediatr Nephrol; 2010 Apr; 25(4):769-78. PubMed ID: 19898875 [TBL] [Abstract][Full Text] [Related]
32. FGF23 and klotho at the intersection of kidney and cardiovascular disease. Edmonston D; Grabner A; Wolf M Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358 [TBL] [Abstract][Full Text] [Related]
33. Vascular calcification and renal bone disorders. Lu KC; Wu CC; Yen JF; Liu WC ScientificWorldJournal; 2014; 2014():637065. PubMed ID: 25136676 [TBL] [Abstract][Full Text] [Related]
35. The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases. Bernheim J; Benchetrit S Nephrol Dial Transplant; 2011 Aug; 26(8):2433-8. PubMed ID: 21543658 [TBL] [Abstract][Full Text] [Related]
36. Phosphate is a vascular toxin. Shroff R Pediatr Nephrol; 2013 Apr; 28(4):583-93. PubMed ID: 23161206 [TBL] [Abstract][Full Text] [Related]
37. [Mineral metabolism in patients on chronic peritoneal dialysis]. Ceballos O ML; Rojo L A; Azócar P M; Ibacache M MJ; Delucchi B A; Quiroz Z L; Irarrázabal M C; Delgado B I; Ugarte P F; Cano Sch F Rev Chil Pediatr; 2014 Feb; 85(1):31-9. PubMed ID: 25079181 [TBL] [Abstract][Full Text] [Related]
38. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury. Epstein M; Freundlich M Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924 [TBL] [Abstract][Full Text] [Related]
39. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Grabner A; Amaral AP; Schramm K; Singh S; Sloan A; Yanucil C; Li J; Shehadeh LA; Hare JM; David V; Martin A; Fornoni A; Di Marco GS; Kentrup D; Reuter S; Mayer AB; Pavenstädt H; Stypmann J; Kuhn C; Hille S; Frey N; Leifheit-Nestler M; Richter B; Haffner D; Abraham R; Bange J; Sperl B; Ullrich A; Brand M; Wolf M; Faul C Cell Metab; 2015 Dec; 22(6):1020-32. PubMed ID: 26437603 [TBL] [Abstract][Full Text] [Related]
40. The role of klotho on vascular calcification and endothelial function in chronic kidney disease. Vervloet MG; Adema AY; Larsson TE; Massy ZA Semin Nephrol; 2014 Nov; 34(6):578-85. PubMed ID: 25498377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]